Instead of developing healthy habits and lifestyles, this particular group might abuse GLP-1s. Most studies on GLP-1s have been conducted on adult participants, so the information available regarding benefits, such as blood sugar control and weight loss, and the cons, such as weight gain with discontinuation, also apply to those in this age group
dose escalation may be delayed by 1 additional week if necessary: Week 1: Inject 0.6 mg subcutaneously once a day Week 2: Inject 1.2 mg subcutaneously once a day Week 3: Inject 1.8 mg subcutaneously once a day Week 4: Inject 2.4 mg subcutaneously once a day Week 5: Inject 3 mg subcutaneously once a day Maintenance dose : 3 mg subcutaneously once a day-If maintenance dose is not tolerated, discontinuation is recommended
Mechanism of Action The drug works by stimulating insulin release, reducing appetite, and slowing down gastric emptying
Peptide therapy does require proper cycling under clinical supervision, which is why we dont recommend sourcing it independently
What is the biggest retatrutide result reported so far
The most important observationmade incidentally by multiple surgeons, but most famously by Gavrill Ilizarov during the 1950s in the Soviet Unionwas that a broken bone, if pulled apart with appropriate timing and stress, can form new bone